Moderna (MRNA) Short Interest Ratio & Short Volume → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free MRNA Stock Alerts $121.89 +0.82 (+0.68%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Moderna Short Interest DataCurrent Short Volume20,980,000 sharesPrevious Short Volume21,440,000 sharesChange Vs. Previous Month-2.15%Dollar Volume Sold Short$2.18 billionShort Interest Ratio / Days to Cover5.6Last Record DateApril 15, 2024Outstanding Shares383,240,000 sharesFloat Size336,370,000 sharesShort Percent of Float6.24%Today's Trading Volume2,505,444 sharesAverage Trading Volume4,110,163 sharesToday's Volume Vs. Average61% Short Selling Moderna ? Sign up to receive the latest short interest report for Moderna and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRNA Short Interest Over TimeMRNA Days to Cover Over TimeMRNA Percentage of Float Shorted Over Time Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> Moderna Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202420,980,000 shares $2.18 billion -2.2%6.2%5.6 $103.86 3/31/202421,440,000 shares $2.28 billion -3.6%6.4%5.2 $106.56 3/15/202422,230,000 shares $2.31 billion +0.5%6.6%5 $103.85 2/29/202422,110,000 shares $2.04 billion -8.2%6.6%4.4 $92.24 2/15/202424,080,000 shares $2.19 billion +15.3%7.2%5 $91.14 1/31/202420,880,000 shares $2.11 billion -9.5%6.3%4.5 $101.05 Get the Latest News and Ratings for MRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. 1/15/202423,070,000 shares $2.44 billion -4.6%7.0%4.5 $105.95 12/31/202324,190,000 shares $2.41 billion +10.6%7.3%4.6 $99.45 12/15/202321,880,000 shares $1.88 billion -0.5%6.6%4.7 $86.01 11/30/202321,990,000 shares $1.71 billion -1.7%6.6%5.4 $77.70 11/15/202322,380,000 shares $1.71 billion +14.1%6.8%5.6 $76.35 10/31/202319,610,000 shares $1.49 billion +8.6%5.9%4.6 $75.96 10/15/202318,050,000 shares $1.77 billion -2.3%5.5%4.5 $98.30 9/30/202318,470,000 shares $1.91 billion +1.7%5.6%4.9 $103.29 9/15/202318,160,000 shares $2.08 billion +0.6%5.5%4.8 $114.59 8/31/202318,050,000 shares $2.04 billion +4.8%5.5%5.1 $113.07 8/15/202317,220,000 shares $1.66 billion +9.2%5.2%4.6 $96.41 7/31/202315,770,000 shares $1.86 billion +1.7%4.8%4.6 $117.66 7/15/202315,510,000 shares $1.88 billion -11.7%4.7%4.8 $121.35 6/30/202317,560,000 shares $2.13 billion -4.2%5.3%5.2 $121.50 6/15/202318,320,000 shares $2.38 billion -2.1%5.5%5.5 $129.98 5/31/202318,720,000 shares $2.39 billion +2.7%5.6%5.6 $127.71 5/15/202318,220,000 shares $2.37 billion +2.1%5.5%5.1 $130.26 4/30/202317,850,000 shares $2.37 billion +6.9%5.4%5.1 $132.89 4/15/202316,700,000 shares $2.62 billion -2.6%5.0%4.7 $157.10 3/31/202317,150,000 shares $2.63 billion +7.9%5.1%4.8 $153.58 3/15/202315,890,000 shares $2.38 billion +1.3%4.7%4 $149.60 2/28/202315,680,000 shares $2.18 billion +6.9%4.7%3.2 $138.81 2/15/202314,670,000 shares $2.60 billion +3.8%4.4%3 $177.28 1/31/202314,130,000 shares $2.49 billion +0.6%4.2%2.9 $176.06 1/15/202314,040,000 shares $2.70 billion No Change4.2%2.7 $192.00 12/30/202214,040,000 shares $2.52 billion -15.8%4.2%2.6 $179.62 12/15/202216,670,000 shares $3.45 billion No Change5.0%3.1 $207.25 11/30/202216,670,000 shares $2.93 billion +4.3%5.0%3.6 $175.91 11/15/202215,980,000 shares $2.96 billion -3.0%4.8%3.3 $185.47 10/31/202216,480,000 shares $2.48 billion +2.0%5.0%3.3 $150.33 10/15/202216,160,000 shares $2.17 billion +2.2%4.8%3.3 $134.00 9/30/202215,810,000 shares $1.87 billion -3.2%4.7%3.5 $118.25 9/15/202216,340,000 shares $2.22 billion +7.4%4.9%3.3 $135.86 8/31/202215,210,000 shares $2.01 billion +1.5%4.5%3.1 $132.27Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> MRNA Short Interest - Frequently Asked Questions What is Moderna's current short interest? Short interest is the volume of Moderna shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 20,980,000 shares of MRNA short. 6.24% of Moderna's shares are currently sold short. Learn More on Moderna's current short interest. What is a good short interest ratio for Moderna? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNA shares currently have a short interest ratio of 6.0. Learn More on Moderna's short interest ratio. Which institutional investors are shorting Moderna? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Moderna: BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Caas Capital Management LP, Simplex Trading LLC, Game Plan Financial Advisors LLC, Nomura Holdings Inc., HAP Trading LLC, Clear Street LLC, CMT Capital Markets Trading GmbH, Cubist Systematic Strategies LLC, PEAK6 Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, IMC Chicago LLC, One River Asset Management LLC, and UBS Group AG. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Moderna? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.24% of Moderna's floating shares are currently sold short. Is Moderna's short interest increasing or decreasing? Moderna saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 20,980,000 shares, a decline of 2.1% from the previous total of 21,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Moderna's float size? Moderna currently has issued a total of 383,240,000 shares. Some of Moderna's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moderna currently has a public float of 336,370,000 shares. How does Moderna's short interest compare to its competitors? 6.24% of Moderna's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Moderna: Seagen Inc. (5.10%), Biogen Inc. (2.26%), argenx SE (2.24%), BioNTech SE (1.33%), Neurocrine Biosciences, Inc. (2.01%), Bio-Techne Co. (3.66%), Gilead Sciences, Inc. (1.70%), Qiagen (1.34%), Repligen Co. (8.85%), CRISPR Therapeutics AG (17.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Moderna stock? Short selling MRNA is an investing strategy that aims to generate trading profit from Moderna as its price is falling. MRNA shares are trading up $0.82 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Moderna? A short squeeze for Moderna occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNA, which in turn drives the price of the stock up even further. How often is Moderna's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Seagen Short Interest Biogen Short Interest argenx Short Interest BioNTech Short Interest Neurocrine Biosciences Short Interest Bio-Techne Short Interest Gilead Sciences Short Interest Qiagen Short Interest Repligen Short Interest CRISPR Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRNA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press